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Abstract
Pancreatic islet transplantation is considered an appropriate treatment to achieve insulin independence in type I diabetic
patients. However, islet isolation and transplantation-induced oxidative stress and autoimmune-mediated destruction are
still the major obstacles to the long-term survival of graft islets in this potential therapy. To protect islet grafts from
inflammatory damage and prolong their survival, we transduced islets with an antioxidative gene thioredoxin (TRX) using
a lentiviral vector before transplantation. We hypothesized that the overexpression of TRX in islets would prolong islet
graft survival when transplanted into diabetic non-obese diabetic (NOD) mice.
Methods
Islets were isolated from NOD mice and transduced with lentivirus carrying TRX  (Lt-TRX) or enhanced green
fluorescence protein (Lt-eGFP), respectively. Transduced islets were transplanted under the left kidney capsule of female
diabetic NOD mice, and blood glucose concentration was monitored daily after transplantation. The histology of the islet
graft was assessed at the end of the study. The protective effect of TRX on islets was investigated.
Results
The lentiviral vector effectively transduced islets without altering the glucose-stimulating insulin-secretory function of
islets. Overexpression of TRX in islets reduced hydrogen peroxide-induced cytotoxicity in vitro. After transplantation
into diabetic NOD mice, euglycemia was maintained for significantly longer in Lt-TRX-transduced islets than in Lt-eGFP-
transduced islets; the mean graft survival was 18 vs. 6.5 days (n = 9 and 10, respectively, p < 0.05).
Conclusion
We successfully transduced the TRX gene into islets and demonstrated that these genetically modified grafts are resistant
to inflammatory insult and survived longer in diabetic recipients. Our results further support the concept that the
reactive oxygen species (ROS) scavenger and antiapoptotic functions of TRX are critical to islet survival after
transplantation.
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Background
Autoimmune diabetes is an inflammatory disease that
causes the loss of insulin-secreting β-cells and hyperglyc-
emia. Islet transplantation can provide near perfect,
moment-by-moment control of the homeostasis of blood
glucose concentration and is much more effective than
insulin injection, which cannot prevent nephropathy,
retinopathy, vascular, and heart disease. However, inflam-
mation, allorejection, and recurrent autoimmune damage
can contribute to early graft loss and are major obstacles
to successful islet transplantation [1]. The process of islet
isolation also triggers a cascade of stressful events in the
islets involving the induction of apoptosis or necrosis and
production of proinflammatory molecules that negatively
influence islet viability and function. Proinflammatory
cytokines such as IL-1β and TNF-α produced by islet-resi-
dent macrophages are toxic to islets and can induce ROS
formation in islet cells [2,3]. Inflammatory cytokines and
free oxygen radicals released in situ can cause apoptosis
and loss of islets after implantation, and eventually graft
failure [4,5].
Previous studies have demonstrated that by using differ-
ent strategies to protect islet from those detrimental
immune response result in greatly improving graft func-
tion and prolonging graft survival. These strategies
include modulating immune response by CTLA-4-Ig or
TGF-β [6,7], inflammatory blockade by chemicals [2,8],
overexpressing antiapoptotic gene Bcl-2 [9], and reducing
oxidative stress by overexpression of antioxidative genes
[10]. However, different animal models used made it dif-
ficult to compare with each work.
Because islets produce very low antioxidative enzymes
and are very sensitive to oxidative stress, clearance of ROS
is crucial in the viability of islet graft. The concept of anti-
oxidative treatment in islets has been proven in many
models, including the transgenic mouse model with spe-
cific expression of antioxidative genes in islets or islet
grafts transduced by viral vector carrying those genes.
Transgenic expression of antioxidant genes in islets, such
as glutathione peroxidase, different isoforms of superox-
ide dismutase, metallothionein, or catalase, significantly
increases the islet viability and reduces ROS formation
after challenge with free radical donor or hypoxia expo-
sure in vitro [11-13]. The role of ROS scavengers in islet
transplantation has also been investigated in these trans-
genic mouse models using syngeneic or allogeneic islet
transplantation. However, only islets from metal-
lothionein transgenic mice showed prolonged islet graft
survival in an allogeneic transplantation model [13]. In
summary, most results regarding that overexpression of
antioxidative genes in islets protects them from oxidative
injury were obtained from in vitro experiments, the in vivo
function and survival of these genetically-modified islets
in diabetic recipients was not clear.
Thioredoxin (TRX) is a small, ubiquitously expressed pro-
tein in the cell. TRX has many biological functions includ-
ing the regulation of the cellular reduction-oxidation
balance, promotion of cell growth, inhibition of apopto-
sis, and regulation of gene expression [14-16]. Previous
studies demonstrated that administration of recombinant
TRX protein reduces brain damage induced by focal cere-
bral ischemia in mice [17]. In other studies, transgenic
overexpression of TRX by the β-actin promoter protected
from the disease or reduced the disease severity in differ-
ent disease models such as acute hepatitis [18] and
ischemic brain injury [19] which are caused mainly by
oxidative stress, indicating that TRX has strong cytoprotec-
tive properties. TRX with antioxidative and antiapoptotic
functions has been demonstrated to prevent β cells from
autoimmune destruction in a β cell-specific TRX trans-
genic NOD model, strongly suggesting that oxidative
stress plays an essential role in the destruction of β cells by
infiltrating inflammatory cells in pancreas [20]. These
results suggested that TRX is a better candidate gene than
other antioxidative genes which may have therapeutic
application in prevention of islet grafts from inflamma-
tory insults. To improve islet grafts viability and maintain
euglycemia after islet transplantation in autoimmune dia-
betes, we used a lentiviral vector delivery system to carry
the  TRX  gene into islets before transplantation. In the
present study, islet cells overexpressing TRX were more
resistant to hydrogen peroxide (H2O2)-induced cell toxic-
ity and had prolonged islet survival after transplant into
diabetic recipients. Our results show that controlling the
inflammation-mediated and ROS-mediated islet graft
damage is critical for successful islet transplantation.
Methods
Animals
NOD/Sytwu (Kd, Db, Ld, I-Ag7) mice were purchased orig-
inally from Jackson Laboratory (Bar Harbor, ME, USA)
and were subsequently bred and maintained under spe-
cific pathogen-free conditions at the Animal Center of the
National Defense Medical Center (Taipei, Taiwan), which
was accredited by AAALAC. Male mice aged 5–8 weeks
were used as islet donor and female mice with blood glu-
cose concentration 300–500 mg/dl were selected as recip-
ients.
Construction of the plasmid and generation of the 
lentivirus
Human TRX cDNA was cloned from A549 (human lung
carcinoma) cells using the primer pair 5'-ggaattcTTTC-
CATCGGTCCTTACAGC-3' and 5'-gaattcGCAGAT-
GGCAACTGGGTTTA-3', and inserted into a pTYEF-
transducing SIN vector. VSV-G-pseudotyped recombinantJournal of Biomedical Science 2009, 16:71 http://www.jbiomedsci.com/content/16/1/71
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HIV-based virus was produced by three-plasmid cotrans-
fection of TE671 cells with the packaging helper construct,
pHP, the envelope expression construct, pHEF-VSV-G,
and the transducing self-inactivating vector carrying the
target gene under control of the elongation factor-1α pro-
moter. The viruses were concentrated by ultracentrifuga-
tion and titered by transduction of confluent TE671 cells
as described before [21].
Islet isolation and viral transduction
Islets were purified from 6-week-old male NOD mice
using the collagenase-digesting method as described pre-
viously [22]. Briefly, the common bile duct was clamped
at its entrance to the duodenum, and 2.5 ml of cold
Hank's balanced salt solution containing 1.5 mg/ml of
collagenase XI (Sigma-Aldrich, St Louis, MO, USA) was
injected into the common bile duct. The islets were incu-
bated in a 37°C water bath for 20 min and then separated
by a density gradient using Histopaque 1077–1 (Sigma-
Aldrich). Finally, islets with a diameter between 75 μm
and 250 μm were handpicked under a dissecting micro-
scope and confirmed by dithizone (Sigma-Aldrich) stain-
ing. Purified islets were suspended in 0.5 ml of culture
medium containing 8 μg/ml polybrene (Sigma-Aldrich)
and infected with lentivirus at a multiplicity of infection
(MOI) of 10. Islet is a 3-dimensional architecture which is
composed by α, β, δ, ε and PP cells and contains on aver-
age 1000 cells. The MOI was calculated according to the
assumption that islets contain on average 1000 cells. Islets
were incubated at 37°C for 3 h with lentivirus in about
0.5 ml of medium and then cultured in F12K (Invitrogen,
Carlsbad, CA, USA) medium supplemented with 10%
fetal bovine serum, 1% penicillin-streptomycin (10,000
units/ml) (Invitrogen), and 1% L-glutamine (2 mmol/l)
(Invitrogen) at 37°C in 5% CO2 before use for transplan-
tation or in vitro analysis. When using the replication-
defective lentiviral vectors to infect islets, only part of cells
surrounded of the islet could be efficiently infected and
the transduction efficiency is around 5% of total islet cells
[23].
In vitro studies of islet cell function
After incubation with lentivirus for 24 h, islets were
washed with RPMI-1640, and a glucose-stimulated insu-
lin-secretion test was performed using Millicell® Cell Cul-
ture Inserts (Corning Inc., Corning, NY, USA). Twenty-five
islets were cultured in the Millicell inserts, washed with
glucose-free RPMI-1640, and then preincubated in RPMI-
1640 containing 2.8 mM glucose for 30 min. Islets were
stimulated first with RPMI-1640 containing 2.8 mM glu-
cose for 1 h and then moved to a second well containing
16.7 mM glucose for an additional 1 h. Insulin released
into the culture medium was measured by ELISA (Merco-
dia, Uppsala, Sweden).
MTT cell viability assay
Forty-eight hours after virus transduction, islets were chal-
lenged with H2O2 at different concentrations (50, 75, and
100 μM) for 18 h. Islet cell viability was measured by the
MTT assay (Sigma-Aldrich) as described previously [24].
RNA extraction and quantitative PCR analysis
Total RNA was extracted using TRIzol reagent (Invitrogen)
and reverse transcribed to cDNA using SuperScript™ III
Reverse transcriptase kit (Invitrogen). PCR for TRX was
run at 35 cycles (45 s of denaturation at 94°C, 45 s of
annealing at 55°C, and 45 s of extension at 72°C), and
the PCR products were separated on a 1.2% agarose gel.
The cDNA was used as a template in the subsequent PCR
analyses. Transcript levels were determined by real-time
PCR using Bio-Rad iCycler and iQ SYBR Green Supermix
(Bio-Rad, Hercules, CA, USA). PCR primers for TRX were
forward 5'-GGAAT TCTTTCCATCGGTCCTTACAGC-3'
and reverse 5'-GGAATTCGCAGATGGCAACTGGGTTTA-
3'. Primers for real-time PCR were list below: forward 5'-
GCCACCAAGGAGGTACACAT-3' and reverse 5'-GCTT-
GTTGCGCTCTATCTCC-3' for HO-1, forward 5'-ATCCTT-
GGAGCCAGTCAAGA-3' and reverse 5'-
ATGATGCCGGAAACAAGAAG-3' for c-fos, forward 5'-
TCCCCTATCGACATGGAGTC-3' and reverse 5'-TTTT-
GCGCTTTCAAGGTTTT-3' for c-jun, forward 5'-ACG-
GTCTGATCCGCAAATAC-3' and reverse 5'-
AGCATGATCGGTTCCACTTG-3' for Rps29 (housekeep-
ing gene).
Transient transfection of reporter gene system
Lt-eGFP- or Lt-TRX-transduced NIT-1 cells (1 × 105/well)
were seeded and maintained in 24-well plate for 24 hours
in F-12K medium and were then transfected with pCMV-
luciferase (Promega, Milan, Italy) and pAP1-SEAP (Clon-
tech, San Jose, CA) at a ratio of 1:50 for 4 hours using the
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) fol-
lowing the manufacturer's recommendations. Transfected
cells were maintained for 20 hours in the complete
medium and then cultured in serum free F-12K medium
for an additional 24 hours. The SEAP activity was deter-
mined in culture supernatants, and luciferase activity was
measured in cell lysates to normalize the transfection effi-
ciency.
Immunoblot analysis of human TRX expression
Total protein from cellular lysate was prepared and size-
fractionated by 15% sodium dodecyl sulfate-polyacryla-
mide gel electrophoresis and electroblotted to onto a
nitrocellulose membrane. The human TRX protein was
detected using the goat anti-human TRX antibody (R&D
systems, Minneapolis, MN).Journal of Biomedical Science 2009, 16:71 http://www.jbiomedsci.com/content/16/1/71
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Islet transplantation
Twenty-four hours after virus transduction, marginal islets
were collected and washed, and a total of around 700
islets were implanted into the left renal capsule of newly
diabetic NOD female mice whose blood glucose concen-
tration was 300–500 mg/dl. Blood glucose concentration
was monitored daily after islet transplantation. Loss of
graft function was defined as a blood glucose concentra-
tion > 300 mg/dl on two consecutive days.
Histological analysis of the grafts
Graft-bearing kidneys were removed on day 7 after trans-
plantation and embedded in OCT for frozen sectioning.
The sections were stained with hematoxylin and eosin
(Sigma-Aldrich). For immunohistochemical analysis, tis-
sue sections were stained with either an insulin (Abcam),
TRX (R&D systems, Minneapolis, MN) or HO-1 (Stress-
gen, Ann Arbor, MI) primary antibody and followed by an
HRP-conjugated secondary antibody. Chromogen sub-
strate 3-3' diaminobenzidine (DAKO, Carpinteria, CA)
was added for enzymatic stain development which
resulted in a brown colored precipitate at the antigen sites.
Mayer's hematoxylin was applied as a counterstain.
Statistical analysis
Insulin secretion and islet viability data were analyzed
using Student's t test and islet graft survival was analyzed
using the Kaplan-Meier method. A p value < 0.05 was
defined as significant.
Results
TRX transgene expression in lentiviral vector-transduced 
islets
The lentiviral vector is an excellent tool for experimental
gene transfer because it infects both dividing and nondi-
viding cells such as pancreatic islets. The transgene carried
by this vector can be stably expressed over the long term
in host cells after virus transduction [25]. To investigate
the transduction efficiency of the lentivirus in the freshly
isolated islets from NOD mice, we transduced islets with
lentivirus at various MOIs and checked the mRNA and
protein levels of the transgene expression after virus trans-
duction. Islets were isolated from 6-week-old male NOD
mice and morphologically intact islets were selected for
the experiment. Islet cells were transduced with the lenti-
virus carrying eGFP or TRX. Transgene expression was
confirmed by fluorescent microscopic imaging for eGFP
protein expression (Fig. 1a) and RT-PCR analysis for
human TRX mRNA expression (Fig. 1b) in lentivirus-
transduced islets. The TRX protein expression in Lt-TRX-
transduced islets was confirmed by an immunoblot anal-
ysis (Fig. 1c). At an MOI of 10, transgenes were expressed
successfully in the islets, and we used an MOI of 10 to
transduce islets in further experiments. Our data demon-
strate that the lentivirus delivered the target genes into
Lentiviral vector-transduced islets Figure 1
Lentiviral vector-transduced islets. (A) Fluorescence 
microscope image displays the eGFP protein expression in 
Lt-eGFP-transduced islets. Original magnification × 200. (B) 
RT-PCR analysis demonstrates TRX mRNA expression in Lt-
TRX-transduced islets. MOI = 10.Journal of Biomedical Science 2009, 16:71 http://www.jbiomedsci.com/content/16/1/71
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islets effectively and that it has potential as a tool for
genetic manipulation in these almost nondividing islets.
Insulin-secreting function of islets after lentivirus 
transduction
The insulin-secreting function of islets is tightly regulated
in response to environmental glucose concentration, and
this control is important for glucose homeostasis. To eval-
uate whether the insulin-secreting function was affected
in lentivirus-transduced islets, a glucose-induced insulin-
secretion assay was performed. One day after virus trans-
duction, islets of similar size and with intact morphology
were selected for the glucose-induced insulin-secretion
assay. The concentration of insulin released into the
medium was measured by ELISA. The concentration of
insulin released into the medium did not differ between
control islets and lentivirus-transduced islets (Fig. 2). Our
data demonstrate that overexpression of eGFP or TRX in
islets did not alter the glucose-stimulated insulin-secret-
ing function of islets, suggesting that in vitro manipulation
of islets by lentivirus did not affect their health or physio-
logical function
H2O2-induced cytotoxicity in Lt-eGFP- or Lt-TRX-
transduced islets
TRX regulates the cellular redox status through its two
cysteine residues and counteracts the toxic effect of ROS.
H2O2 is toxic to cells at low concentrations, and this toxic-
ity can be neutralized by TRX. To evaluate the protective
effect of transgenic TRX on the islet damage mediated by
oxidative stress, we used H2O2 as a ROS donor to induce
islet cell death and investigated the protective effect of
TRX on islets under H2O2 stimulation. Lt-eGFP- and Lt-
TRX-transduced islets were incubated with various con-
centrations of H2O2 for 18 h, and the MTT assay was per-
formed to evaluate the islet cell viability. Islet cells
overexpressing TRX were more resistant to H2O2-induced
cytotoxicity at a concentration of 100 μM (Fig. 3). These
data indicate that overexpression of TRX in islets by the
lentiviral vector did not affect the insulin-secreting func-
tion of islets and further protected the islets from exoge-
nous stress stimulation, suggesting that TRX is a potential
candidate for genetic manipulation of islet grafts in trans-
plantation.
Survival of TRX-transduced islet grafts after 
transplantation
Oxidative stress induced by inflammation and islet isola-
tion and transplantation are major obstacles to islet
replacement therapy because they may cause primary
non-function of islets and early graft loss. Considering the
advantages of the antioxidative and antiapoptotic func-
tions of TRX, we hypothesized that overexpression of this
gene would protect islets from the stress induced by the
transplantation procedure and subsequent autoimmune
attack. Freshly isolated islets were transduced with Lt-TRX
or Lt-eGFP and cultured for 1 day. Around 700 marginal
islets were transplanted under the left kidney capsule of
newly diabetic female NOD mice. Islet grafts with TRX
transduction showed better glycemic control (Fig. 4a) and
prolonged islet graft survival in diabetic recipients (mean
graft survival days, 18 vs. 6.5, n = 9 and 10, respectively, p
< 0.05) (Fig. 4b). We also performed nephrectomy of the
Insulin-secreting function of islets Figure 2
Insulin-secreting function of islets. Freshly isolated islets 
were transduced with Lt-eGFP or Lt-TRX. After 24 h cul-
ture, the glucose-stimulated insulin-secretion test was per-
formed. The concentration of insulin released into the 
medium was measured by ELISA. The concentration of insu-
lin release is expressed as mean ± SD of three independent 
experiments.
Overexpression of TRX reduces H2O2-induced cytotoxicity Figure 3
Overexpression of TRX reduces H2O2-induced cyto-
toxicity. Freshly isolated islets were transduced with Lt-
eGFP or Lt-TRX. After 48 h culture, islets were treated with 
H2O2 at different concentrations for 18 h. Islet cell viability 
was measured by the MTT assay. The viability results are 
expressed as mean ± SD of three independent experiments.Journal of Biomedical Science 2009, 16:71 http://www.jbiomedsci.com/content/16/1/71
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left kidney implanted with grafted islets to confirm further
the glucose-regulatory function of the Lt-TRX-transduced
islet grafts. The NOD recipients with normal glycemia
became hyperglycemic after the islet-implanted kidney
was removed, indicating that the islet grafts were still
functional and maintained the normal glycemia in trans-
planted recipients (data not shown). Histological analysis
of the graft-bearing kidneys revealed that although Lt-
TRX-transduced islets showed much less leukocytic infil-
tration than the Lt-eGFP-transduced islets, they were not
completely free from lymphocyte infiltration (Fig. 5a and
5b). Immunohistochemical staining showed that Lt-TRX
transduced islet grafts were insulin-producing (Fig. 5c)
and TRX-expressing (Fig. 5d), suggesting that these islets
with transgene expression were still functional. Since
heme oxygenase-1 (HO-1) mediates a strong cytoprotec-
tion in cells under a variety of stresses, the induction of
HO-1 in TRX-transduced islets may have a synergistic
effect with TRX to protect them from apoptosis and
improve islet survival and function after transplantation.
Results from immunohistochemical staining revealed that
the distribution of HO-1-expressing cells was quite close
to that of the TRX-expressing cells (Fig. 5e), consistent
with the previous reports that TRX facilitates the induction
of HO-1 [26]. These results indicate that overexpression of
TRX in islet grafts protected them from inflammation-
induced stress and prolonged graft survival after trans-
plantation, although it could not inhibit leukocytic infil-
tration completely and prevent loss of the grafts.
Cellular responses to the TRX overexpression
Previous reports have demonstrated that TRX selectively
activates a number transcription factors and facilitates the
induction of cytoprotective genes [14], suggesting that
TRX-mediated islet graft protection may not only acts
through free radical scavenger. To investigate the protec-
tive mechanisms mediated by TRX in islet grafts, we fur-
ther analyzed the expression of genes such as c-fos, c-jun,
and HO-1 that were regulated by TRX. We also analyzed
AP-1 activity in β cell-derived NIT-1 cells after Lt-TRX virus
transduction. Quantitative PCR analysis reveals that
expression of HO-1 and c-fos was up-regulated after Lt-
TRX transduction (Fig. 6a).
To further determine the AP-1 activity in Lt-TRX-trans-
duced cells, we transfected cells with a SEAP reporter plas-
mid which containing AP-1 binding sites on the upstream
promoter region. The AP-1 activity was around 3-fold
increase in Lt-TRX-transduced cells than in Lt-eGFP-trans-
duced cells, suggesting that TRX could regulate gene tran-
scription through the up-regulation of AP-1 activity (Fig.
6b). These results are consistent with previous reports that
TRX regulates cellular redox status and promotes cell sur-
vival through inducing cell protective genes expression.
Discussion
Clinical trials of islet transplantation are showing remark-
able success since the Edmonton protocol [27] was devel-
oped, and this glucocorticoid-free immunosuppressive
protocol was replicated successfully [28]. However, inad-
equate islet donors and recurrent autoimmunity are major
obstacles in the treatment of type I diabetes. The trans-
plantation procedure such as collagenase-based islet isola-
tion triggers proinflammatory cytokine and chemokine
production by islets, which contributes to early graft loss
or primary loss of function [3,29]. In this study, we over-
expressed TRX in islet grafts to determine whether this
would protect them from oxidative stress-induced cell
damage. We found that TRX did not alter the glucose-
induced insulin-secreting function of the islets but pro-
Function of marginal islets and diabetic-free frequency of dia- betic recipients Figure 4
Function of marginal islets and diabetic-free fre-
quency of diabetic recipients. (A) Mean blood glucose 
concentration in mice that received Lt-eGFP- or Lt-TRX-
transduced islets. Data are expressed as the mean ± SD from 
10 mice in each group. (B) Lt-TRX-transduced islets main-
tained euglycemia for significantly longer than in the Lt-eGFP-
transduced group. Blood glucose concentration was moni-
tored daily after islet implantation. Loss of graft function was 
defined as a blood glucose concentration > 300 mg/dl on two 
consecutive days.Journal of Biomedical Science 2009, 16:71 http://www.jbiomedsci.com/content/16/1/71
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Histology of islet grafts (IG) under the capsule (CA) of the kidney (K) Figure 5
Histology of islet grafts (IG) under the capsule (CA) of the kidney (K). Lt-eGFP- and Lt-TRX-transduced islets were 
transplanted into diabetic NOD mice in the same operation. IG-implanted kidneys were removed on day 7 when the Lt-TRX-
transduced IG was still functional and maintained euglycemia, but the Lt-eGFP-transduced IG had failed. (A) Severe leukocytic 
penetration was observed in Lt-eGFP-transduced IG. (B) Lt-TRX-transduced IG had less severe leukocytic infiltration and islet 
cells were still visible. Serial sections of Lt-TRX transduced islet grafts were immunohistochemically stained with insulin (C), 
TRX (D) and HO-1 (E). Arrows in (D) and (E) point out examples of the TRX and HO-1 staining respectively and arrow heads 
point out the infiltrated lymphocytes. Original magnification × 100.Journal of Biomedical Science 2009, 16:71 http://www.jbiomedsci.com/content/16/1/71
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tected them from ROS challenge. In the islet transplanta-
tion experiment, TRX-overexpressed islets showed better
glycemic control and longer graft survival, indicating that
TRX has a strong cytoprotective effect on islets.
Many approaches have been shown to have protective
effects in islets, including the regulation of the immune
response by overexpressing anti-inflammatory cytokines
or cytokine inhibitors [6,30,31]; and by reducing cellular
stress by overexpression of antiapoptotic and antioxida-
tive genes in islets [9,10,12]. These approaches might pro-
tect islets from apoptosis or promote islet function in vitro
or in vivo, although the choice of target genes and the
methods to overexpress the target genes can affect the
results significantly. In general, therapeutic targets that
have a paracrine action have a more marked biological
effect than do genes that target intracellular molecules. In
addition, the selected vectors for carrying the target genes
to the islets should have low immunogenicity, and long-
term and stable gene expression in islets is required. In
this work, we used a lentivirus to carry the TRX gene into
the islets, which do not divide or have a low rate of divi-
sion. This approach has some advantages. First, lentivirus
can infect both dividing and nondividing or quiescent
cells efficiently and provide for the stable integration into
the host cell genome. Second, this method does not elicit
an immune response in vivo. Third, TRX is a strong ROS
scavenger in the cytoplasm and can clear H2O2 directly
and repair the oxidized proteins.
TRX also regulates the expression or activity of other pro-
teins. In some circumstances, TRX translocates to the
nucleus to regulate transcription factor activity [32] or can
be secreted and act as a growth factor [33]. Under stimu-
lation by inflammatory mediators, TRX regulates AP-1
activity and enhances heme oxygenase-1 (HO-1) expres-
sion [26]. The AP-1 activity was around 3-fold increase in
Lt-TRX-transduced cells than in Lt-GFP-transduced cells,
suggesting that TRX could regulate gene transcription
through the up-regulation of AP-1 activity in our model.
HO-1 expression was observed in Lt-TRX-transduced islets
and induction of HO-1 in islet grafts have been demon-
strated to protect them from apoptosis and improve their
function after transplantation [34]. Thus, TRX and HO-1
may play coordinated roles in protecting cells from
inflammatory stress. The reduced form of TRX also binds
to a variety of cellular proteins. Apoptosis signal-regulat-
ing kinase 1 (ASK1) is one TRX-binding protein that medi-
ates stress- and cytokine-mediated apoptosis [35]. TRX
binds to the N-terminus of ASK1, and activation of ASK1
requires dissociation of the TRX [16,36]. Taken together,
the antioxidative and antiapoptotic functions of TRX may
contribute to protecting islets from inflammation-
induced cell injury.
Conclusion
It is unlikely that any single biological agent will be suffi-
cient to stop such complicated autoimmune processes
such as cytokine imbalance, free radical formation, and
cellular apoptosis [37]. Using newly diabetic NOD mice
that had developed strong autoimmunity to pancreatic
islets as the recipients, we showed that TRX can prolong
graft survival significantly. This effect may reflect the mul-
Cellular responses to TRX overexpressing Figure 6
Cellular responses to TRX overexpressing. (A) Levels 
of mRNA of HO-1, c-jun and c-fos genes in Lt-eGFP- or Lt-
TRX-transduced cells. The mRNA was measured by real-
time PCR. Results are shown as a ratio of indicated gene to 
Rps29 (housekeeping gene). Results are the mean ± S.E.M. of 
triplicates from three independent experiments. (B) Lt-
eGFP- or Lt-TRX-transduced NIT-1 cells were transiently 
transfected with pCMV-luciferase and pAP1-SEAP plasmids. 
SEAP activity in culture supernatants was determined and 
normalized for luciferase activity in the cell lysates. Data are 
shown as means ± S.E.M. of triplicates from three independ-
ent experiments.Journal of Biomedical Science 2009, 16:71 http://www.jbiomedsci.com/content/16/1/71
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tiple biological functions of TRX, which has both antioxi-
dative and antiapoptotic activities. These are important
functions for preventing islets from immune attack, and
this idea has been demonstrated in the transgenic model
[20]. However, despite its beneficial effects, TRX could not
inhibit the leukocytic infiltration into the islet grafts com-
pletely, and future studies using combinations of immu-
noregulatory genes may help prolong graft survival and
maintain long-term glucose homeostasis in diabetic recip-
ients.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
FCC ried out the molecular genetic studies, participated in
the sequence alignment and drafted the manuscript, par-
ticipated in the design of the study and performed the sta-
tistical analysis, conceived of the study, and participated
in its design and coordination and helped to draft the
manuscript. HKS carried out the molecular genetic stud-
ies, participated in the sequence alignment and drafted
the manuscript, participated in the design of the study and
performed the statistical analysis, conceived of the study,
and participated in its design and coordination and
helped to draft the manuscript
Acknowledgements
This work was supported by the National Science Council, Taiwan, ROC 
(NSC96-2628-B-016-002-MY3 to H.-K. Sytwu). We thank Shing-Jia Shieh 
for technical assistance.
References
1. Gysemans CA, Waer M, Valckx D, Laureys JM, Mihkalsky D, Bouillon
R, Mathieu C: Early graft failure of xenogeneic islets in NOD
mice is accompanied by high levels of interleukin-1 and low
levels of transforming growth factor-beta mRNA in the
grafts.  Diabetes 2000, 49:1992-1997.
2. Matsuda T, Omori K, Vuong T, Pascual M, Valiente L, Ferreri K,
Todorov I, Kuroda Y, Smith CV, Kandeel F, Mullen Y: Inhibition of
p38 pathway suppresses human islet production of pro-
inflammatory cytokines and improves islet graft function.
Am J Transplant 2005, 5:484-493.
3. Bottino R, Balamurugan AN, Tse H, Thirunavukkarasu C, Ge X, Pro-
fozich J, Milton M, Ziegenfuss A, Trucco M, Piganelli JD: Response of
human islets to isolation stress and the effect of antioxidant
treatment.  Diabetes 2004, 53:2559-2568.
4. Corbett JA, Sweetland MA, Wang JL, Lancaster JR Jr, McDaniel ML:
Nitric oxide mediates cytokine-induced inhibition of insulin
secretion by human islets of Langerhans.  Proc Natl Acad Sci USA
1993, 90:1731-1735.
5. Barshes NR, Wyllie S, Goss JA: Inflammation-mediated dysfunc-
tion and apoptosis in pancreatic islet transplantation: impli-
cations for intrahepatic grafts.  J Leukoc Biol 2005, 77:587-597.
6. Suarez-Pinzon WL, Marcoux Y, Ghahary A, Rabinovitch A: Gene
transfection and expression of transforming growth factor-
beta1 in nonobese diabetic mouse islets protects beta-cells
in syngeneic islet grafts from autoimmune destruction.  Cell
Transplant 2002, 11:519-528.
7. Fernandes JR, Duvivier-Kali VF, Keegan M, Hollister-Lock J, Omer A,
Su S, Bonner-Weir S, Feng S, Lee JS, Mulligan RC, Weir GC: Trans-
plantation of islets transduced with CTLA4-Ig and TGFbeta
using adenovirus and lentivirus vectors.  Transpl Immunol 2004,
13:191-200.
8. Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, Nadler JL: The
novel anti-inflammatory agent lisofylline prevents autoim-
mune diabetic recurrence after islet transplantation.  Trans-
plantation 2004, 77:55-60.
9. Contreras JL, Bilbao G, Smyth CA, Jiang XL, Eckhoff DE, Jenkins SM,
Thomas FT, Curiel DT, Thomas JM: Cytoprotection of pancreatic
islets before and soon after transplantation by gene transfer
of the anti-apoptotic Bcl-2 gene.  Transplantation 2001,
71:1015-1023.
10. Bertera S, Crawford ML, Alexander AM, Papworth GD, Watkins SC,
Robbins PD, Trucco M: Gene transfer of manganese superoxide
dismutase extends islet graft function in a mouse model of
autoimmune diabetes.  Diabetes 2003, 52:387-393.
11. Chen H, Li X, Epstein PN: MnSOD and catalase transgenes
demonstrate that protection of islets from oxidative stress
does not alter cytokine toxicity.  Diabetes 2005, 54:1437-1446.
12. Mysore TB, Shinkel TA, Collins J, Salvaris EJ, Fisicaro N, Murray-Segal
LJ, Johnson LE, Lepore DA, Walters SN, Stokes R, et al.: Overex-
pression of glutathione peroxidase with two isoforms of
superoxide dismutase protects mouse islets from oxidative
injury and improves islet graft function.  Diabetes 2005,
54:2109-2116.
13. Li X, Chen H, Epstein PN: Metallothionein protects islets from
hypoxia and extends islet graft survival by scavenging most
kinds of reactive oxygen species.  J Biol Chem 2004, 279:765-771.
14. Powis G, Montfort WR: Properties and biological activities of
thioredoxins.  Annu Rev Biophys Biomol Struct 2001, 30:421-455.
15. Burke-Gaffney A, Callister ME, Nakamura H: Thioredoxin: friend
or foe in human disease?  Trends Pharmacol Sci 2005, 26:398-404.
16. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawa-
bata M, Miyazono K, Ichijo H: Mammalian thioredoxin is a direct
inhibitor of apoptosis signal-regulating kinase (ASK) 1.  Embo
J 1998, 17:2596-2606.
17. Hattori I, Takagi Y, Nakamura H, Nozaki K, Bai J, Kondo N, Sugino T,
Nishimura M, Hashimoto N, Yodoi J: Intravenous administration
of thioredoxin decreases brain damage following transient
focal cerebral ischemia in mice.  Antioxid Redox Signal 2004,
6:81-87.
18. Okuyama H, Nakamura H, Shimahara Y, Araya S, Kawada N,
Yamaoka Y, Yodoi J: Overexpression of thioredoxin prevents
acute hepatitis caused by thioacetamide or lipopolysaccha-
ride in mice.  Hepatology 2003, 37:1015-1025.
19. Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, Hashim-
oto N, Yodoi J: Overexpression of thioredoxin in transgenic
mice attenuates focal ischemic brain damage.  Proc Natl Acad
Sci USA 1999, 96:4131-4136.
20. Hotta M, Tashiro F, Ikegami H, Niwa H, Ogihara T, Yodoi J, Miyazaki
J: Pancreatic beta cell-specific expression of thioredoxin, an
antioxidative and antiapoptotic protein, prevents autoim-
mune and streptozotocin-induced diabetes.  J Exp Med 1998,
188:1445-1451.
21. Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J: Efficacy and
safety analyses of a recombinant human immunodeficiency
virus type 1 derived vector system.  Gene Ther 1999, 6:715-728.
22. Juang JH, Kuo CH, Hsu BR: Effects of multiple site implantation
on islet transplantation.  Transplant Proc 2002, 34:2698-2699.
23. Curran MA, Ochoa MS, Molano RD, Pileggi A, Inverardi L, Kenyon
NS, Nolan GP, Ricordi C, Fenjves ES: Efficient transduction of
pancreatic islets by feline immunodeficiency virus vectors1.
Transplantation 2002, 74:299-306.
24. Janjic D, Wollheim CB: Islet cell metabolism is reflected by the
MTT (tetrazolium) colorimetric assay.  Diabetologia 1992,
35:482-485.
25. Bottino R, Lemarchand P, Trucco M, Giannoukakis N: Gene- and
cell-based therapeutics for type I diabetes mellitus.  Gene Ther
2003, 10:875-889.
26. Wiesel P, Foster LC, Pellacani A, Layne MD, Hsieh CM, Huggins GS,
Strauss P, Yet SF, Perrella MA: Thioredoxin facilitates the induc-
tion of heme oxygenase-1 in response to inflammatory medi-
ators.  J Biol Chem 2000, 275:24840-24846.
27. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL,
Kneteman NM, Rajotte RV: Islet transplantation in seven
patients with type 1 diabetes mellitus using a glucocorticoid-
free immunosuppressive regimen.  The New England journal of
medicine 2000, 343:230-238.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Biomedical Science 2009, 16:71 http://www.jbiomedsci.com/content/16/1/71
Page 10 of 10
(page number not for citation purposes)
28. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robert-
son RP, Secchi A, Brendel MD, Berney T, Brennan DC, et al.: Inter-
national trial of the Edmonton protocol for islet
transplantation.  The New England journal of medicine 2006,
355:1318-1330.
29. Abdelli S, Ansite J, Roduit R, Borsello T, Matsumoto I, Sawada T, Alla-
man-Pillet N, Henry H, Beckmann JS, Hering BJ, Bonny C: Intracel-
lular stress signaling pathways activated during human islet
preparation and following acute cytokine exposure.  Diabetes
2004, 53:2815-2823.
30. Gallichan WS, Kafri T, Krahl T, Verma IM, Sarvetnick N: Lentivirus-
mediated transduction of islet grafts with interleukin 4
Results in sustained gene expression and protection from
insulitis.  Human gene therapy 1998, 9:2717-2726.
31. Deng S, Ketchum RJ, Yang ZD, Kucher T, Weber M, Shaked A, Naji
A, Brayman KL: IL-10 and TGF-beta gene transfer to rodent
islets: effect on xenogeneic islet graft survival in naive and B-
cell-deficient mice.  Transplant Proc 1997, 29:2207-2208.
32. Hayashi T, Ueno Y, Okamoto T: Oxidoreductive regulation of
nuclear factor kappa B. Involvement of a cellular reducing
catalyst thioredoxin.  J Biol Chem 1993, 268:11380-11388.
33. Hori K, Katayama M, Sato N, Ishii K, Waga S, Yodoi J: Neuroprotec-
tion by glial cells through adult T cell leukemia-derived fac-
tor/human thioredoxin (ADF/TRX).  Brain research 1994,
652:304-310.
34. Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, Oliver R,
Fraker C, Ricordi C, Pastori RL, Bach FH, Inverardi L: Heme oxyge-
nase-1 induction in islet cells Results in protection from
apoptosis and improved in vivo function after transplanta-
tion.  Diabetes 2001, 50:1983-1991.
35. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi
M, Matsumoto K, Miyazono K, Gotoh Y: Induction of apoptosis by
ASK1, a mammalian MAPKKK that activates SAPK/JNK and
p38 signaling pathways.  Science 1997, 275:90-94.
36. Liu H, Nishitoh H, Ichijo H, Kyriakis JM: Activation of apoptosis
signal-regulating kinase 1 (ASK1) by tumor necrosis factor
receptor-associated factor 2 requires prior dissociation of
the ASK1 inhibitor thioredoxin.  Mol Cell Biol 2000,
20:2198-2208.
37. Chernajovsky Y, Gould DJ, Podhajcer OL: Gene therapy for
autoimmune diseases: quo vadis?  Nat Rev Immunol 2004,
4:800-811.